InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
60%
T+90 mean return
+3.6%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by LORANGER STEVEN R, Director. Officer active across 2 companies, notably Edwards Lifesciences Corp. Cumulatively, 11 reports have been published. Activity tracked since 5 May 2021. The latest transaction was filed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
3,528 shares0Common StockSEC:0001225208-25-004954:0
5,739 shares@ US$45.3167100.0% of flowCommon StockSEC:0001225208-25-001751:0
3,055 shares0Common StockSEC:0001225208-24-005898:0
1,580 shares0Common StockSEC:0001562180-23-004395:0
2,803 shares0Common StockSEC:0001225208-23-005908:0
1,812 shares0Common StockSEC:0001209191-22-029334:0
2,300 shares0Common StockSEC:0001225208-22-006590:0
1,328 shares0Common StockSEC:0001209191-21-032357:0
1,328 shares0Common StockSEC:0001209191-21-032357
2,615 shares0Common StockSEC:0001225208-21-007756
2,615 shares0Common StockSEC:0001225208-21-007756:0
11 of 11 declarations
About LORANGER STEVEN R
Steven R. Loranger is a Director at Edwards Lifesciences Corp and Xylem Inc. In this role, he participates in the strategic direction of these companies and important decision-making. His expertise in the healthcare and water technology sectors is valuable to the board.
